Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantation

By Glanemann M.   Langrehr J.M.   Raakow R.   Guckelberger O.   Lohmann R.   Klupp J.   Lobeck H.   Schlag H.   Keck H.   Bechstein W.O.   Settmacher U.   Neuhaus P.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2159-2160

Elsevier

Access to resources Recommend Favorite

Pancreas Transplantation Versus Islet Transplantation Versus Insulin Therapy in the Prevention of Nephropathy in Alloxan-Induced Diabetic Rats

By Spadella C.T.   Schellini S.A.   Bacchi C.E.  

Transplantation Proceedings, Vol. 30, Iss. 2, 1998-03 ,pp. : 327-329

Elsevier

Access to resources Recommend Favorite

Anti-CD4/CyA Therapy Causes Prevention of Autoimmune but Not Allogeneic Destruction of Grafted Islets in BB Rats

By Kuttler B.   Rosing K.   Hahn H.J.  

Transplantation Proceedings, Vol. 29, Iss. 4, 1997-06 ,pp. : 2163-2165

Elsevier

Access to resources Recommend Favorite

Immunological effects of the anti-IL-2 receptor monoclonal antibody BT 563 in liver allografted patients

By Nashan B.   Schwinzer R.   Schlitt H.   Wonigeit K.   Pichlmayr R.  

Transplant Immunology, Vol. 3, Iss. 3, 1995-09 ,pp. : 203-211

Elsevier

Access to resources Recommend Favorite

Selective immunosuppression with fk 506, anti-il-2r, and anti-icam-1 monoclonal antibodies: contrasting effects after liver and small bowel transplantation in rats

By Otto C.   Gasser M.   Gassel H.-J.   Steger U.   Timmermann W.   Meyer D.   Ulrichs K.   Thiede A.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2161-2162

Elsevier

Access to resources Recommend Favorite